Altogether, our data support the idea that Cat D deletion controls TAM polarization from immune-suppressive M2 to immune-stimulatory M1 subtypes through TGFBI and CCL20 secretion, which in turn leads to suppression of tumor metastasis and growth. Here, TGFBI is linked to neoplasm.